Subscribe To
Down 30% in a month, is there more pain for chemocentryx stock?
The stock price of ChemoCentryx, a biopharmaceuticals company focused on orally-administered therapeuti...
February 1, 2022, 6:00 am
Mizuho's vamil divan reveals his top biotech pick
AbbVie Inc (NYSE: ABBV) closed 2021 with a 25% gain in the stock price, and Mizuho's senior biopharmaceuticals...
January 28, 2022, 5:04 pm
Mizuho's vamil divan reveals his top biotech pick
AbbVie Inc (NYSE: ABBV) closed 2021 with a 25% gain in the stock price, and Mizuho's senior biopharmaceuticals...
January 28, 2022, 5:04 pm
Mizuho's vamil divan reveals his top biotech pick
AbbVie Inc (NYSE: ABBV) closed 2021 with a 25% gain in the stock price, and Mizuho's senior biopharmaceuticals...
January 28, 2022, 5:04 pm
Navidea biopharmaceuticals, inc. (navb) q3 2021 results - earnings call transcript
Navidea Biopharmaceuticals, Inc. (NAVB) Q3 2021 Results - Earnings Call Transcript...
November 11, 2021, 12:21 am
Navidea biopharmaceuticals, inc. (navb) q3 2021 results - earnings call transcript
Navidea Biopharmaceuticals, Inc. (NAVB) Q3 2021 Results - Earnings Call Transcript...
November 11, 2021, 12:21 am
Navidea biopharmaceuticals, inc. (navb) q3 2021 results - earnings call transcript
Navidea Biopharmaceuticals, Inc. (NAVB) Q3 2021 Results - Earnings Call Transcript...
November 11, 2021, 12:21 am
Researchers identify thymosin beta 4's potential role in treatment of acute kidney injury and the reduction of mortality in patients with sepsis
ROCKVILLE, Md., Oct. 6, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company...
October 6, 2021, 9:20 am
Researchers identify thymosin beta 4's potential role in treatment of acute kidney injury and the reduction of mortality in patients with sepsis
ROCKVILLE, Md., Oct. 6, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company...
October 6, 2021, 9:20 am
Researchers identify thymosin beta 4's potential role in treatment of acute kidney injury and the reduction of mortality in patients with sepsis
ROCKVILLE, Md., Oct. 6, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company...
October 6, 2021, 9:20 am